Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective. [electronic resource]
Producer: 19960924Description: 35-40 p. digitalISSN:- 0002-9149
- Abciximab
- Angioplasty, Balloon, Coronary
- Antibodies, Monoclonal -- therapeutic use
- Atherectomy, Coronary
- Constriction, Pathologic
- Eptifibatide
- Humans
- Immunoglobulin Fab Fragments -- therapeutic use
- Peptides -- therapeutic use
- Platelet Aggregation Inhibitors -- therapeutic use
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Randomized Controlled Trials as Topic
- Recurrence
- Stents
- Tirofiban
- Treatment Outcome
- Tyrosine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.